Search

News & Reports

Evonik Industries

INVESTOR RELATIONS

Here you can find "Investor Relations News" with the latest news from our company, plus our most recent interim reports, annual reports and corporate responsibility reports.


Evonik has published its quarterly report Q4 2017 on March 06, 2018. You can access further information here.

Reporting 2018

November 6, 2018

Reporting Q3 2018

August 2, 2018

Reporting Q2 2018

May 8, 2018

Reporting Q1 2018

March 6, 2018

Reporting Q4 2017 and Annual Report 2017

Further information

Here you will find Evonik's Investor Relations News.

more
 

Evonik Industries AG acquires Specialty & Coating Additive business of Air Products.

more
 

Exceptional achievements are driven by a readiness to strike out in new directions. For further information about Evonik, please refer to our business reports.

more
 

Here you will find our quarterly reports.

more
 

Evonik wants to be a reliable and fair partner that takes responsibility for its actions. Please click here for further information on Responsible Care at Evonik.

more
 

Find the detailed overview of key financial data for Download here.
more

 
, Investors

Evonik to close its Kaba site in Hungary


Essen (Germany) / Kaba (Hungary). Evonik will stop its amino acid production at its Hungarian Kaba site by the end of April 2018. There Evonik Agroferm Zrt., a subsidiary of Evonik, currently employs about 120 people.

More
, Investors

Evonik plans new polyamide 12 complex in Marl


• Evonik's largest investment in Germany
• Targeted strengthening of the Resource Efficiency growth segment
• Strong growth for high-performance polymer polyamide 12 in the automotive sector, the oil and gas industry, and 3D printing

More
, Investors

A good performance in 2017


• Forecast fully achieved: Adjusted EBITDA of €2.36 billion is at the upper end of the range
• Outlook for 2018: Sales and earnings growth,
adjusted EBITDA between €2.4 billion and €2.6 billion
• Active portfolio management: Examining strategic options for the methacrylates business

More
more

Disclaimer

more